Literature DB >> 16146427

LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells.

Jane E Murphy1, Daryl Tacon, Philip R Tedbury, Jonathan M Hadden, Stuart Knowling, Tatsuya Sawamura, Michelle Peckham, Simon E V Phillips, John H Walker, Sreenivasan Ponnambalam.   

Abstract

The LOX-1 (lectin-like oxidized low-density lipoprotein receptor-1) scavenger receptor regulates vascular responses to oxidized-low-density-lipoprotein particles implicated in atherosclerotic plaque formation. LOX-1 is closely related to C-type lectins, but the mechanism of ligand recognition is not known. Here we show that human LOX-1 recognizes a key cellular phospholipid, PS (phosphatidylserine), in a Ca2+-dependent manner, both in vitro and in cultured cells. A recombinant, folded and glycosylated LOX-1 molecule binds PS, but not other phospholipids. LOX-1 recognition of PS was maximal in the presence of millimolar Ca2+ levels. Mg2+ was unable to substitute for Ca2+ in LOX-1 binding to PS, indicating a Ca2+-specific requirement for bivalent cations. LOX-1-mediated recognition of PS-containing apoptotic bodies was dependent on Ca2+ and was decreased to background levels by bivalent-cation chelation, LOX-1-blocking antibodies or PS-containing liposomes. The LOX-1 membrane protein is thus a Ca2+-dependent phospholipid receptor, revealing novel recognition of phospholipids by mammalian lectins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16146427      PMCID: PMC1383669          DOI: 10.1042/BJ20051166

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

Review 1.  Roles of the NKG2D immunoreceptor and its ligands.

Authors:  David H Raulet
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

Review 2.  Mechanisms and functions of cell death.

Authors:  R E Ellis; J Y Yuan; H R Horvitz
Journal:  Annu Rev Cell Biol       Date:  1991

3.  CD 69 antigen of human lymphocytes is a calcium-dependent carbohydrate-binding protein.

Authors:  K Bezouska; A Nepovím; O Horváth; M Pospísil; J Hamann; T Feizi
Journal:  Biochem Biophys Res Commun       Date:  1995-03-08       Impact factor: 3.575

4.  Protein lipid overlay assay.

Authors:  Simon Dowler; Gursant Kular; Dario R Alessi
Journal:  Sci STKE       Date:  2002-04-23

5.  Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction.

Authors:  R Mango; F Clementi; P Borgiani; G B Forleo; M Federici; G Contino; E Giardina; L Garza; I E Fahdi; R Lauro; J L Mehta; G Novelli; F Romeo
Journal:  J Med Genet       Date:  2003-12       Impact factor: 6.318

6.  Oxidized LDL through LOX-1 modulates LDL-receptor expression in human coronary artery endothelial cells.

Authors:  Bo Hu; Dayuan Li; Tatsuya Sawamura; Jawahar L Mehta
Journal:  Biochem Biophys Res Commun       Date:  2003-08-08       Impact factor: 3.575

Review 7.  The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.

Authors:  Mohamad Navab; G M Ananthramaiah; Srinivasa T Reddy; Brian J Van Lenten; Benjamin J Ansell; Gregg C Fonarow; Kambiz Vahabzadeh; Susan Hama; Greg Hough; Naeimeh Kamranpour; Judith A Berliner; Aldons J Lusis; Alan M Fogelman
Journal:  J Lipid Res       Date:  2004-04-01       Impact factor: 5.922

8.  LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells.

Authors:  Dayuan Li; Ling Liu; Hongjiang Chen; Tatsuya Sawamura; Subramanian Ranganathan; Jawahar L Mehta
Journal:  Circulation       Date:  2003-02-04       Impact factor: 29.690

9.  LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells.

Authors:  Dayuan Li; Ling Liu; Hongjiang Chen; Tatsuya Sawamura; Jawahar L Mehta
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-03-13       Impact factor: 8.311

10.  Phagocytosis of apoptotic bodies by liver endothelial cells.

Authors:  L Dini; A Lentini; G D Diez; M Rocha; L Falasca; L Serafino; F Vidal-Vanaclocha
Journal:  J Cell Sci       Date:  1995-03       Impact factor: 5.285

View more
  27 in total

1.  Dynamics of lung macrophage activation in response to helminth infection.

Authors:  Mark C Siracusa; Joshua J Reece; Joseph F Urban; Alan L Scott
Journal:  J Leukoc Biol       Date:  2008-08-21       Impact factor: 4.962

Review 2.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Authors:  Irena Levitan; Suncica Volkov; Papasani V Subbaiah
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

Review 3.  The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex.

Authors:  Jianhui Xie
Journal:  Glycoconj J       Date:  2012-07-12       Impact factor: 2.916

4.  Chaperonin-containing TCP-1 complex directly binds to the cytoplasmic domain of the LOX-1 receptor.

Authors:  Deenadayalan Bakthavatsalam; Roh Hun Soung; David J Tweardy; Wah Chiu; Richard A F Dixon; Darren G Woodside
Journal:  FEBS Lett       Date:  2014-05-17       Impact factor: 4.124

5.  Chlamydia pneumoniae binds to the lectin-like oxidized LDL receptor for infection of endothelial cells.

Authors:  Lee Ann Campbell; Mirja Puolakkainen; Amy Lee; Michael E Rosenfeld; H Jacques Garrigues; Cho-Chou Kuo
Journal:  Microbes Infect       Date:  2011-08-30       Impact factor: 2.700

6.  Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells.

Authors:  Takaharu Ichimura; Edwin J P V Asseldonk; Benjamin D Humphreys; Lakshman Gunaratnam; Jeremy S Duffield; Joseph V Bonventre
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 7.  The discovery of LOX-1, its ligands and clinical significance.

Authors:  Ryo Yoshimoto; Yoshiko Fujita; Akemi Kakino; Shin Iwamoto; Tomohide Takaya; Tatsuya Sawamura
Journal:  Cardiovasc Drugs Ther       Date:  2011-10       Impact factor: 3.727

8.  The LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular Disease.

Authors:  M W Twigg; K Freestone; S Homer-Vanniasinkam; S Ponnambalam
Journal:  Cardiol Res Pract       Date:  2012-02-19       Impact factor: 1.866

Review 9.  Clinical and Preclinical Use of LOX-1-Specific Antibodies in Diagnostics and Therapeutics.

Authors:  Jonathan De Siqueira; Izma Abdul Zani; David A Russell; Stephen B Wheatcroft; Sreenivasan Ponnambalam; Shervanthi Homer-Vanniasinkam
Journal:  J Cardiovasc Transl Res       Date:  2015-09-18       Impact factor: 4.132

Review 10.  The Phagocytic Code Regulating Phagocytosis of Mammalian Cells.

Authors:  Tom O J Cockram; Jacob M Dundee; Alma S Popescu; Guy C Brown
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.